University of North Texas Health Science Center

The Inner Circle Acknowledges, David R. Danly as a Distinguished Healthcare Professional for his contributions to the fields of Child and Adolescent Psychiatry

Retrieved on: 
Friday, October 13, 2023

TYLER, Texas, Oct. 13, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, David R. Danly is acknowledged as a Distinguished Healthcare Professional for his contributions to the fields of Child and Adolescent Psychiatry.

Key Points: 
  • TYLER, Texas, Oct. 13, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, David R. Danly is acknowledged as a Distinguished Healthcare Professional for his contributions to the fields of Child and Adolescent Psychiatry.
  • Dr. Danly pursued higher education at John P. and Katherine G. McGovern Medical School at UTHealth where he graduated in 1988.
  • He completed a residency in psychiatry in 1992 and a fellowship in child & adolescent psychiatry in 1994 at the University of Texas Health Science Center at Houston.
  • According to Dr. Danly, the center's mission is to provide and coordinate high-quality integrated healthcare services to the East Texas community to achieve independence and well-being.

TECHealth, An Emergency Services Company names Jeff Erdner, D.O., President Texas Division

Retrieved on: 
Wednesday, August 23, 2023

CHANDLER, Ariz., Aug. 23, 2023 /PRNewswire-PRWeb/ -- Jeff Erdner, D.O. has been named President Texas Division of TECHealth, An Emergency Services Company.

Key Points: 
  • has been named President Texas Division of TECHealth, An Emergency Services Company.
  • has been named President Texas Division of TECHealth, An Emergency Services Company.
  • As President Texas Division, Dr. Erdner will oversee the continued growth of emergency services for TECHealth in Texas.
  • TECHealth, An Emergency Services Company, offers an array of business operations and clinical services solutions to improve emergency medicine.

Dr. Eric Beck Succeeds ESO Founder Chris Dillie as CEO

Retrieved on: 
Tuesday, August 8, 2023

ESO , the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, state and federal agencies today announced Eric Beck as new CEO.

Key Points: 
  • ESO , the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, state and federal agencies today announced Eric Beck as new CEO.
  • Beck will oversee ESO’s growth strategy and continue to accelerate ESO’s mission to improve community health and safety through the power of data.
  • Founder and former CEO, Chris Dillie, will move into an Executive Chair role on the ESO board as part of the planned succession.
  • “In his 10 years at ESO as a board member and, more recently, president, Eric has already made a significant impact on the organization,” said Dillie.

$25,000 Cash is Up for Grabs. EOSERA Calls for Applications for the Second-Annual EmpowHERment Pitch Competition for Female-Led, Texas-Based Companies

Retrieved on: 
Tuesday, July 25, 2023

FORT WORTH, Texas, July 25, 2023 /PRNewswire/ -- Fort Worth-based success story EOSERA, INC. wants to pay it forward again by hosting the second-annual EmpowHERment Pitch Competition with the help of partners Simmons Bank, Higginbotham, Satori Capital, Tech Fort Worth, and UNT Health Science Center. CEO of EOSERA, Elyse Stoltz Dickerson, got her start by winning a pitch competition, and now wants to give another smart, innovative, female-led, Texas-based company that same opportunity. 

Key Points: 
  • EOSERA,® INC. is hosting the second-annual EmpowHERment pitch competition with partners Simmons Bank, Higginbotham, Satori Capital, Tech Fort Worth, and UNT Health Science Center.
  • With three finalists, the first-place prize is $15,000 sponsored by Simmons Bank, and the second-place prize is $10,000 sponsored by Higginbotham.
  • FORT WORTH, Texas, July 25, 2023 /PRNewswire/ -- Fort Worth-based success story EOSERA, INC. wants to pay it forward again by hosting the second-annual EmpowHERment Pitch Competition with the help of partners Simmons Bank , Higginbotham , Satori Capital , Tech Fort Worth , and UNT Health Science Center .
  • CEO of EOSERA, Elyse Stoltz Dickerson, got her start by winning a pitch competition, and now wants to give another smart, innovative, female-led, Texas-based company that same opportunity.

Lawsuit Filed Against Midland Baptist Daycare for Alleged Mistreatment of 3-Year-Old Boy

Retrieved on: 
Tuesday, May 30, 2023

MIDLAND, Texas, May 30, 2023 /PRNewswire/ -- A Midland mom is suing Greenwood Baptist Children's Learning Center, claiming caregivers caused her 3-year-old son physical, emotional, and psychological harm after leaving him in a kitchen pantry with the lights off, spraying him with toxic disinfectant, and forcing him to sit next to a trash can for an excessive amount of time. The lawsuit also claims that the daycare violated state laws by waiting several days to report the incidents to the boy's mother and the state of Texas.

Key Points: 
  • The lawsuit also claims that the daycare violated state laws by waiting several days to report the incidents to the boy's mother and the state of Texas.
  • The complaint continues that the church's board, director, and staff were aware of the wide mistreatment of children, including the boy in this case.
  • "We are committed to holding the daycare accountable and, hopefully, in the process of this lawsuit, protect other children in the Midland community from suffering similar traumatic experiences."
  • The case is Josefina Aguillon, Individually and as Parent and Next Friend of E.A., a minor child, vs. Greenwood Baptist Church of Midland, Texas, d/b/a Greenwood Baptist Children's Learning Center, Cause No.

ContraFect Announces Multiple Presentations of New Data at the 33rd Annual ECCMID Meeting

Retrieved on: 
Thursday, April 6, 2023

YONKERS, N.Y., April 06, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, announces today that the Company has been selected for an oral presentation and three poster presentations at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Annual Meeting to be held from April 15-18, 2023 in Copenhagen, Denmark. The data being presented will feature both exebacase and CF-370, the Company’s lead product candidates with CF-370 demonstrating potent in vitro bactericidal activity against drug-resistant pathogens, including multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains.

Key Points: 
  • YONKERS, N.Y., April 06, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, announces today that the Company has been selected for an oral presentation and three poster presentations at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Annual Meeting to be held from April 15-18, 2023 in Copenhagen, Denmark.
  • The data being presented will feature both exebacase and CF-370, the Company’s lead product candidates with CF-370 demonstrating potent in vitro bactericidal activity against drug-resistant pathogens, including multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains.
  • Title: Efficacy of lysin CF-370 in addition to amikacin in a neutropenic rabbit lung infection model caused by an extensively drug-resistant (XDR) P. aeruginosa
    Presenting Author: Mark Pulse, University of North Texas Health Science Center, College of Pharmacy

AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries

Retrieved on: 
Wednesday, March 29, 2023

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) [NYSE: CVS].

Key Points: 
  • AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) [NYSE: CVS].
  • Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICRs of “a” (Excellent) of Texas Health + Aetna Health Insurance Company, as well as Texas Health + Aetna Health Plan Inc.
  • Texas Health Aetna and Allina Health and Aetna Insurance Company are joint ventures with subsidiaries of Aetna Inc.
  • The ratings of Aetna Health & Life Group reflect the ultimate parent, CVS Health, and an expectation of elevated leverage due to the recently announced acquisitions.

MedCognetics Awarded $750,000 Grant from NIH to Research Unbiased Artificial Intelligence for Breast Cancer Detection

Retrieved on: 
Thursday, January 26, 2023

The company is a subaward from the University of North Texas Health Science Center (HSC) at Fort Worth, Texas.

Key Points: 
  • The company is a subaward from the University of North Texas Health Science Center (HSC) at Fort Worth, Texas.
  • “We selected MedCognetics as one of our grant recipients because of its focus on developing technology aimed at addressing the data bias of historically ignored populations, especially regarding breast health and imaging.
  • Its partnership with the University of Texas Southwestern Medical Center (UTSW) provided the clinical data that assisted in the validation of its unbiased AI algorithm.
  • This NIH grant will play an important role in future product development as well as helping us further expand our global market penetration.”

EOSERA Announces Boozy Bites as the First-ever EmpowHERment Pitch Competition Winner

Retrieved on: 
Friday, November 18, 2022

FORT WORTH, Texas, Nov. 18, 2022 /PRNewswire/ -- Three companies competed at EOSERA's inaugural EmpowHERment Pitch Competition in Fort Worth on November 17th, 2022, but only one walked away with the $10K grand prize. After pitching for 8 minutes with 4 minutes of Q&A, 3 qualified judges selected founder Dee Dee Bryant of Boozy Bites as the first EmpowHERment Pitch Competition winner.

Key Points: 
  • After pitching for 8 minutes with 4 minutes of Q&A, 3 qualified judges selected founder Dee Dee Bryant of Boozy Bites as the first EmpowHERment Pitch Competition winner.
  • Boozy Bites also competed against PWR WMNthe people's choice award winner of $2,500another woman-led company that makes blazers with pockets that are functional and feminine.
  • EOSERA's EmpowHERment Pitch Competition will be an annual competition held during Global Entrepreneurship Week every November.
  • "We are thrilled for and proud of Boozy Bites for being the first to win the EmpowHERment Pitch Competition," says EOSERA CEO, Elyse Stoltz Dickerson.

EOSERA Announces Three EmpowHERment Pitch Finalists; One Woman-Led Company Will Win $10K

Retrieved on: 
Thursday, October 20, 2022

FORT WORTH, Texas, Oct. 20, 2022 /PRNewswire/ -- Boozy Bites, Heralogie, and PWR WMN have been selected finalists and will compete for the $10k prize in EOSERA® INC.'s inaugural EmpowHERment Pitch Competition. Elyse Stoltz Dickerson, CEO of the Fort Worth-based success story got an early jump start by winning a pitch competition and is giving these three smart, innovative, woman-led, Texas-based companies a similar opportunity. 

Key Points: 
  • FORT WORTH, Texas, Oct. 20, 2022 /PRNewswire/ -- Boozy Bites, Heralogie, and PWR WMN have been selected finalists and will compete for the $10k prize in EOSERA INC.'s inaugural EmpowHERment Pitch Competition.
  • The EmpowHERment Pitch Competition will be an annual competition held during Global Entrepreneurship Week every November.
  • When EOSERA won their pitch competition, it propelled our company forward and took us to the next level.
  • EOSERA, Inc. is a biotech company that develops innovative products that target under addressed healthcare needs in the ear care space.